Year: 2023

Novo Nordisk’s 340B Arkansas Lawsuit Reassigned to Judge Who Previously Ruled Against Drugmakers

November 9, 2023 Views

Novo Nordisk and the Arkansas Insurance Department are at odds over whether a federal district court should intervene in the enforcement of Arkansas' 340B contract pharmacy law.

A federal district court transferred drugmaker Novo Nordisk’s lawsuit challenging Arkansas’ 340B contract pharmacy law to a judge who previously [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Louisiana Provider Group to Intervene in 340B Contract Pharmacy Lawsuit

November 9, 2023 Views

A federal district judge allowed the Louisiana Primary Care Association's to intervene in a second drug industry lawsuit challenging Louisiana's 340B contract pharmacy law.

A federal judge allowed a Louisiana provider group to join the state attorney general in defending Louisiana’s 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Hospitals Charge Higher Commercial Insurance Prices, Says PhRMA Funded Report

November 9, 2023 Views

Neil Masia, Ph.D., authored a Health Capital Group report that found 340B hospitals charge higher commercial insurance prices than non-340B hospitals.

The average hospital in the 340B program charges commercial insurers more than non-340B hospitals, according to a new report, which [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Senate Committee Doubles Down on PBM Bill with 340B Spread Pricing Language

November 9, 2023 Views

Sen. Ron Wyden (D-Ore.), chairman of the Senate Finance Committee, announced a Dec. 5 hearing on prescription drug shortages that will include testimony from two witnesses who have published research on the 340B program.

Members of the Senate Finance Committee yesterday reiterated support for a pharmacy benefit manager (PBM) transparency bill with 340B spread [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Indiana Health Care Leaders Call for 340B Transparency in Op-Ed

November 9, 2023 Views

Two Indiana Health Center leaders—TJ Warren (left) and Ben Harvey (right)—called for greater 340B program transparency in a recent op-ed.

The CEOs of an Indiana-based community health center and a primary care association recently wrote an op-ed that called for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GlaxoSmithKline Posts Refund Notice on HRSA Website

November 9, 2023 Views

GlaxoSmithKline and Pfizer announced updates to their 340B contract pharmacy policies to comply with new state laws that will take effect in July.

GlaxoSmithKline owes refunds to 340B providers, according to a notice posted on the Health Resources and Services Administration’s Office of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Expert Tip from The Craneware Group

November 9, 2023 Views

Genesis Ruling Could Expand 340B-Eligible Prescriptions, Say Some Attorneys

November 7, 2023 Views

Kyle Vasquez, an attorney for Polsinelli, said the Genesis ruling was "limited in reach" but could create obstacles for other HRSA enforcement activity.

A recent ruling by a federal district judge in South Carolina potentially could expand 340B-eligible prescriptions, say some provider advisers. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospitals Urge CMS to Reconsider Future Cuts in 340B Lump Sum Final Rule

November 7, 2023 Views

Tom Kraus, a vice president of the American Society of Health-System Pharmacists, said he was "deeply concerned" with future cuts in CMS' 340B lump sum final rule.

Hospital advocates praised the recent Medicare final rule implementing a $9 billion lump sum payment to 340B hospitals but worried [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Lilly Reinstates Tighter 340B Contract Pharmacy Restrictions

November 7, 2023 Views

Eli Lilly is conducting government approved 340B provider audits that for the first time look for certain Medicaid health plan duplicate discounts.

Pharmaceutical giant Eli Lilly this week announced it would reinstate tighter 340B contract pharmacy restrictions for all covered entity types. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live